Mazzella L J, Pazhanisamy S, Pratt R F
Department of Chemistry, Wesleyan University, Middletown, CT 06457.
Biochem J. 1991 Mar 15;274 ( Pt 3)(Pt 3):855-9. doi: 10.1042/bj2740855.
The Ser-70----Gly mutant of the TEM-1 beta-lactamase, where the active-site serine hydroxy group has been lost, does not catalyse the hydrolysis of either benzylpenicillin or N-(phenylacetyl)glycyl depsipeptides. This is as would be expected for a double-displacement mechanism where the Ser-70 becomes acylated at an intermediate stage. Further, however, the mutant enzyme, unlike the wild-type, does not catalyse aminolysis of depsipeptides by D-phenylalanine. If the active site is not structurally disrupted by the mutation, this result shows that Ser-70 is necessary for the aminolysis reaction and implies that this reaction, like the hydrolysis, proceeds by way of an acyl-(serine)-enzyme intermediate. Although physical evidence suggests that the mutant enzyme does not have a structure in solution identical with that of the wild-type, the mutant does still bind beta-lactam substrates. The latter result suggests sufficient conservation of the active-site structure for the major conclusion above to hold.
TEM-1β-内酰胺酶的Ser-70→Gly突变体,其活性位点的丝氨酸羟基已缺失,既不能催化苄青霉素水解,也不能催化N-(苯乙酰基)甘氨酰缩肽水解。这与双位移机制预期的情况相符,在该机制中Ser-70在中间阶段会被酰化。然而,进一步研究发现,与野生型不同,突变酶不能催化D-苯丙氨酸对缩肽的氨解反应。如果活性位点没有因突变而在结构上被破坏,这一结果表明Ser-70对于氨解反应是必需的,并且意味着该反应与水解反应一样,通过酰基-(丝氨酸)-酶中间体进行。尽管物理证据表明突变酶在溶液中的结构与野生型不同,但突变体仍能结合β-内酰胺底物。后一结果表明活性位点结构有足够的保守性,以使上述主要结论成立。